These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 9658400

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) stimulates corticotroph function via a signal transducer and activator of transcription-dependent mechanism negatively regulated by suppressor of cytokine signaling-3.
    Auernhammer CJ, Isele NB, Kopp FB, Spoettl G, Cengic N, Weber MM, Senaldi G, Engelhardt D.
    Endocrinology; 2003 Apr; 144(4):1202-10. PubMed ID: 12639901
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
    Auernhammer CJ, Kopp FB, Vlotides G, Dorn F, Isele NB, Spöttl G, Cengic N, Weber MM, Senaldi G, Engelhardt D.
    Neuroimmunomodulation; 2004 Apr; 11(4):224-32. PubMed ID: 15249728
    [Abstract] [Full Text] [Related]

  • 6. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW, Ren SG, Melmed S.
    J Clin Invest; 1996 Apr 15; 97(8):1852-9. PubMed ID: 8621768
    [Abstract] [Full Text] [Related]

  • 7. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C, Chesnokova V, Kariagina A, Ferrand A, Melmed S.
    Mol Endocrinol; 2001 Nov 15; 15(11):1880-90. PubMed ID: 11682619
    [Abstract] [Full Text] [Related]

  • 8. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
    Abbud RA, Kelleher R, Melmed S.
    Endocrinology; 2004 Feb 15; 145(2):867-80. PubMed ID: 14576184
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
    Chesnokova V, Kariagina A, Melmed S.
    Am J Physiol Endocrinol Metab; 2002 May 15; 282(5):E1110-8. PubMed ID: 11934677
    [Abstract] [Full Text] [Related]

  • 12. Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ, Chesnokova V, Melmed S.
    Endocrinology; 1998 May 15; 139(5):2201-8. PubMed ID: 9564823
    [Abstract] [Full Text] [Related]

  • 13. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C, Zatelli MC, Melmed S.
    J Clin Invest; 2000 Dec 15; 106(11):1417-25. PubMed ID: 11104795
    [Abstract] [Full Text] [Related]

  • 14. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
    Chesnokova V, Melmed S.
    Endocrinology; 2000 Nov 15; 141(11):4032-40. PubMed ID: 11089533
    [Abstract] [Full Text] [Related]

  • 15. Critical role for STAT3 in murine pituitary adrenocorticotropin hormone leukemia inhibitory factor signaling.
    Bousquet C, Melmed S.
    J Biol Chem; 1999 Apr 16; 274(16):10723-30. PubMed ID: 10196143
    [Abstract] [Full Text] [Related]

  • 16. Leukemia inhibitory factor regulates proopiomelanocortin transcription.
    Ray DW, Ren SG, Melmed S.
    Ann N Y Acad Sci; 1998 May 01; 840():162-73. PubMed ID: 9629248
    [Abstract] [Full Text] [Related]

  • 17. Leukemia inhibitory factor (LIF) induces acute adrenocorticotrophic hormone (ACTH) secretion in fetal rhesus macaque primates: a novel dynamic test of pituitary function.
    Akita S, Conn PM, Melmed S.
    J Clin Endocrinol Metab; 1996 Nov 01; 81(11):4170-8. PubMed ID: 8923879
    [Abstract] [Full Text] [Related]

  • 18. gp130-Dependent signalling pathway is not enhanced in gp130 transgenic heart after LIF stimulation.
    Tone E, Kunisada K, Kumanogoh A, Negoro S, Funamoto M, Osugi T, Kishimoto T, Yamauchi-Takihara K.
    Cytokine; 2000 Oct 01; 12(10):1512-8. PubMed ID: 11023666
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.
    Chesnokova V, Auernhammer CJ, Melmed S.
    Endocrinology; 1998 May 01; 139(5):2209-16. PubMed ID: 9564824
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.